NOVEL THERAPY NEWS
New
Treatments for Hepatitis C
… maybe
2008
February
Scientists in the land down under work to bring us a vaccine for hep C.
... cool.
New Hope for
Hepatitis C Sufferers
Newswise (press release) – USA
Newswise — Adelaide scientists will
lead a $2 million five-year project to develop new vaccines and explore
better treatment options for hepatitis C ...
The
first protease inhibitor out of the chute’s now looking at a problem of
drug resistance – in other words, the virus beats the drug – adding this
to their not-so-impressive numbers.
Vertex’s lead drug
telaprevir for the treatment of Hepatitis C ...
Financial Times - London,England,UK
Reimbursement and pricing will also
have to be taken into consideration, as many patients on Hepatitis C
treatment have to take an additional EPO product to ...
January
While we
could give a rip about Human Genome Sciences stock market rating, what
happened here is that when they upped the dose in their clinical
trial, people taking the drug started getting heart problems. ... this
we care about.
Human Genome
Sciences shares fall on hepatitis C drug results
Daily Record (subscription) - Baltimore,MD,USA
... said it would modify trials of
an experimental drug to treat hepatitis C after some patients receiving
higher dosages experienced serious side effects. ...
Telapravir – formerly known as VX-950 – trial results: good news & bad
news. The bad news ... it doesn’t work; the good news: used with
peg-interferon & ribavirin, it might cut the treatment time in half.
... bummer.
Vertex Under the Gun
Motley Fool – USA
Vertex announced yesterday that it
was advancing its lead hepatitis C drug, telaprevir, into phase 3
trials, yet the market promptly took its shares to lows ...
2007
December 2007
One of the
reasons treatment can be too hard to endure is cuz the peg interferon
can cause an abrupt drop in our platelet counts. Here’s some news
stories on a drug that may be able to do something about that.
Eltrombopag
Effective for Hepatitis C Patients With Low Blood ...
Newswise (press release) – USA
Newswise — For
patients with hepatitis C, having a low blood platelet count is a
frequent complication associated with advanced disease. ...
Eltrombopag
effective for hepatitis C patients with low blood ...
HULIQ - Hickory,NC,USA
For patients
with hepatitis C, having a low blood platelet count is a frequent
complication associated with advanced disease. This problem is
compounded by ...
Drug helps boost
blood-platelets in Hep C
Earthtimes - London,UK
28 A report in the New England
Journal of Medicine says the drug eltrombopag appears to significantly
boost platelet counts in hepatitis C patients. ...
back to da top
|